(object) array( 'id' => '1467655', 'url' => 'SR/Lamictal', 'image' => '', 'title' => 'Lamictal', 'tags' => array ( 0 => 'Lamictal', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamictal', 'source_id' => 31148, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210502', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju epilepsije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845761, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamictal', 'Definition' => 'a prescription drug used to treat epilepsy', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamictal', )

(object) array( 'id' => '1461308', 'url' => 'SR/performance_improvement_plan', 'image' => '', 'title' => 'plan za unapređenje radnog učinka', 'tags' => array ( 0 => 'plan za unapređenje radnog učinka', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'plan za unapređenje radnog učinka', 'source_id' => 40103, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222513', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Plan obuke koji podstiče konstruktivne diskusije između zaposlenih i nadređenih povodom načina na koji radni učinak može biti unapređen.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813697, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'performance improvement plan', 'Definition' => 'Training plan which encourages constructive discussion between employees and supervisors regarding how work performance can be improved.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'performance_improvement_plan', )

(object) array( 'id' => '1461004', 'url' => 'SR/double-blind_study', 'image' => '', 'title' => 'duplo-slepa studija', 'tags' => array ( 0 => 'duplo-slepa studija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'duplo-slepa studija', 'source_id' => 30890, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Klinička studija u kojoj ni pojedinci koji u njoj učestvuju ni stručna lica koja studiju sprovode ne znaju koji ispitanici dobijaju eksperimentalni lek a koji placebo(ili drugu terapiju). Smatra se da duplo-slepa studija daje objektivne rezultate, pošto očekivanja lekara i ispitanika vezana za eksperimentalni lek ne utiču negativno na sam ishod:poznata još pod nazivom duplo-maskirana studija. Vidi slepa-studija,jednostruko-slepa studija i placebo', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907778, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'double-blind study', 'Definition' => 'A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study. See Blinded Study, Single-Blind Study, and Placebo.', 'Synonym' => 'double-masked study_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'double-blind_study', )

(object) array( 'id' => '1467659', 'url' => 'SR/Nevirapine', 'image' => '', 'title' => 'Nevirapine', 'tags' => array ( 0 => 'Nevirapine', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Nevirapine', 'source_id' => 31154, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210508', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju odraslih koji su HIV pozitivni sa deterioracijom imunog sistema', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845765, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Nevirapine', 'Definition' => 'a prescription drug used to treat HIV-positive adults who show immulogical deterioration', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Nevirapine', )

(object) array( 'id' => '1460564', 'url' => 'SR/cohort', 'image' => '', 'title' => 'kohorta', 'tags' => array ( 0 => 'kohorta', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'kohorta', 'source_id' => 30879, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705074506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'U epidemiologiji, grupa pojedinaca sa nekim sličnim karakteristikama.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325250, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'cohort', 'Definition' => 'In epidemiology, a group of individuals with some characteristics in common.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'cohort', )

(object) array( 'id' => '1461006', 'url' => 'SR/orphan_drugs', 'image' => '', 'title' => 'lekovi ,,siročići\'\'', 'tags' => array ( 0 => 'lekovi ,,siročići\'\'', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'lekovi ,,siročići\'\'', 'source_id' => 30914, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kategorija Administracije za hranu i lekove koja se odnosi na lekove koji se koriste u lečenju retkih bolesti i stanja. Slabo ima finansijske motivacije za farmaceutsku industriju u pogčedu razvoja lekova za ovakve bolesti i stanja. Status lekova ,,siročića\'\', u svakom slučaju daje proizvođaču posebnu finansijsku motivaciju za razvoj i obezbeđivanje takvih lekova.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907780, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'orphan drugs', 'Definition' => 'An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. Orphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'orphan_drugs', )

(object) array( 'id' => '1461052', 'url' => 'SR/quality_of_life_trials', 'image' => '', 'title' => 'Ispitivanja kvaliteta života', 'tags' => array ( 0 => 'Ispitivanja kvaliteta života', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Ispitivanja kvaliteta života', 'source_id' => 30923, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155514', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na ispitivanja koja proučavaju načine za poboljšanje konfora i kvaliteta života kod pojedinaca sa hroničnim oboljenjima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966610505729, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'quality of life trials', 'Definition' => 'Refers to trials that explore ways to improve comfort and quality of life for individuals with a chronic illness.', 'Synonym' => 'supportive care trials_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'quality_of_life_trials', )

(object) array( 'id' => '1467639', 'url' => 'SR/randomization', 'image' => '', 'title' => 'randomizacija', 'tags' => array ( 0 => 'randomizacija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'randomizacija', 'source_id' => 30924, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709204516', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Metod zasnovan na slučajnosti kojom su ispitanici studije svrstani u određenu grupu za lečenje. Randomizaija smanjuje razliku između grupa time što jednako distribuira ljude sa odeređenim karakteristikama u sve grupe ispitivanja. Istraživači ne znaju koji način lečenja je bolji. Ono što je poznato je da svaki od načina lečenja može biti koristan za ispitanika.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999171936260, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'randomization', 'Definition' => 'A method based on chance by which study participants are assigned to a treatment group. Randomization minimizes the differences among groups by equally distributing people with particular characteristics among all the trial arms. The researchers do not know which treatment is better. From what is known at the time, any one of the treatments chosen could be of benefit to the participant.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'randomization', )

(object) array( 'id' => '1461310', 'url' => 'SR/personal_file_access_policy', 'image' => '', 'title' => 'Politika pristupa ličnim fajlovima', 'tags' => array ( 0 => 'Politika pristupa ličnim fajlovima', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Politika pristupa ličnim fajlovima', 'source_id' => 40104, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705223509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Politika koja dozvoljava sadašnjim i ranijim zaposlenima pristup svojim fajlovima, pod uslovom da unpared o tome obaveste menadžera za ljudske resurse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813699, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'personal file access policy', 'Definition' => 'A policy allowing current and prior employees access to their own files, provided they let HR know in advance.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'personal_file_access_policy', )

(object) array( 'id' => '1460602', 'url' => 'SR/modularization', 'image' => '', 'title' => 'modularizacija', 'tags' => array ( 0 => 'modularizacija', 1 => 'Education', 2 => 'Teaching', 3 => 'Teachnology', 4 => '', ), 'term' => 'modularizacija', 'source_id' => 712326, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Education', ), 'category' => array ( 0 => 'Teaching', ), 'company' => array ( 0 => 'Teachnology', ), 'lastedit' => '20110705082506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Obrazovni proces koji razdvaja materijal ili kurseva na module čime se studentima omogućava felksibilnost u izabirz modula priliko kreiranja programa studiranja.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964694757376, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'modularization', 'Company' => 'Teachnology', 'Definition' => 'Teaching process that splits material or courses into modules to allow students flexibility in selecting modules to create a program of study.', 'Domain' => 'Documentation', 'Industry' => 'Education', 'Part of Speech' => 'noun', 'Product Category' => 'Teaching', 'Usage Status' => 'New', 'Creation User' => 'katesd', 'Creation Date' => '2011/2/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'modularization', )